Your cart is empty.
Macl-GPIb alpha Interaction Library

Macl-GPIb alpha Interaction Library

Files to download
Preferred format
Desirable size of the custom library selection
Number of compounds
Amount
Volume
uL
Description

The ChemDiv library contains 27 000 compounds targeted at Macl-GPIb alpha Interaction.

Leukocyte-platelet interaction is important in mediating leukocyte adhesion to a thrombus and leukocyte recruitment to a site of vascular injury. This interaction is mediated by the β2-integrin Mac-1 (also known as integrin αMβ2) and its counter-receptor on platelets, glycoprotein Ibalpha (GPIb), a component of the GP Ib-IX-V complex, the platelet von Willebrand factor (vWf) receptor. [1]

Studies showed that the Macl-GPIb alpha interaction involves the Mac-1 I domain (homologous to the vWf A1 domain), and the GPIb leucine-rich repeat and COOH-terminal flanking regions. Since leukocyte–platelet interactions bidirectionally induce signals that amplify pro-inflammatory and pro-thrombotic cellular responses, it provides a molecular target for disrupting leukocyte-platelet complexes that promote vascular inflammation in thrombosis, atherosclerosis, and angioplasty-related restenosis. [2]

Current anti-thrombotic drugs, including antiplatelet agents and anticoagulants, are associated with significant bleeding risk and increased mortality. It was shown that small-molecule targeting of Mac-1-GPIb interaction successfully inhibits thrombosis. Moreover, it was identified that targeting this interaction has anti-thrombotic therapeutic potential with reduced bleeding risk. [1]

[1]         Y. Wang et al., “Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα,” Nat. Commun., vol. 8, no. May, 2017, doi: 10.1038/ncomms15559.

[2]         D. I. Simon et al., “Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18),” J. Exp. Med., vol. 192, no. 2, pp. 193–204, 2000, doi: 10.1084/jem.192.2.193.

X
X
Send a message
Request a call

Your Name*

Your E-mail*

Company*

Type in your message here…*
* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.


Your Name*

Your Phone*

Company*

* Required fields

By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.